AKOYA BIOSCIENCES INC (AKYA)       12.33  +0.53 (+4.49%)

12.33  +0.53 (+4.49%)

US00974H1041 - Common Stock - After market: 12.33 0 (0%)

AKOYA BIOSCIENCES INC12.33

NASDAQ:AKYA (12/8/2022, 7:25:00 PM)+0.53 (+4.49%)

After market: 12.33 0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Life Sciences Tools & Services
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 11-07 2022-11-07/amc Earnings (Next) 03-13 2023-03-13
Ins Owners 4.36% Inst Owners 37.6%
Market Cap 468.00M Shares 37.96M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 86.15
IPO 04-16 2021-04-16

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AKYA Daily chart

Company Profile

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company is headquartered in Marlborough, Massachusetts and currently employs 149 full-time employees. The company went IPO on 2021-04-16. The firm deliveries spatial biology solutions, which is focused on transforming discovery and clinical research. Spatial biology technology enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single-cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through its PhenoCycler and PhenoImager platform, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research. The company provides PhenoImager HT, which is a digital pathology slide scanner featuring MOTiF whole-slide multispectral scanning of up to seven biomarkers with an 80-slide capacity. The company offers contract research services laboratory, which is called as advanced biopharma solutions.

Company Info

AKOYA BIOSCIENCES INC

100 Campus Drive, 6Th Floor

Marlborough MASSACHUSETTS

P: 18558968401.0

CEO: Brian McKelligon

Employees: 149

Website: https://www.akoyabio.com/

AKYA News

News Imagea month ago - Akoya Biosciences, Inc.Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance

Q3 2022 revenue $18.9 million, 40% y/y growthRaising FY 2022 revenue guidance range to $73-75 million MARLBOROUGH, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE)...

News Imagea month ago - Akoya Biosciences, Inc.Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer ImmunotherapyNews Imagea month ago - Akoya Biosciences, Inc.Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue GuidanceNews Imagea month ago - Akoya Biosciences, Inc.Akoya to Participate at Three Upcoming Investor Conferences

MARLBOROUGH, Mass., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

News Imagea month ago - Akoya Biosciences, Inc.Akoya to Participate at Three Upcoming Investor ConferencesNews Image2 months ago - Akoya Biosciences, Inc.Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced...

AKYA Twits

Here you can normally see the latest stock twits on AKYA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example